NovoLog PenFill and Obinutuzumab Intravenous
Determining the interaction of NovoLog PenFill and Obinutuzumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: obinutuzumab
Brand name: Gazyva
Synonyms: Obinutuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog PenFill-Obizur
- NovoLog PenFill-Obizur Intravenous
- NovoLog PenFill-Obredon
- NovoLog PenFill-Ocaliva
- NovoLog PenFill-Occlucort
- NovoLog PenFill-Occlusal-HP Topical
- Obinutuzumab Intravenous-Novoseven
- Obinutuzumab Intravenous-NovoSeven RT
- Obinutuzumab Intravenous-NovoSeven RT with MixPro injection
- Obinutuzumab Intravenous-Novothyrox
- Obinutuzumab Intravenous-Noxafil
- Obinutuzumab Intravenous-Noxafil (Posaconazole Delayed-Release Tablets)